Treatment, privacy concerns arise with availability of Alzheimer's test

11/15/2012 | New York Times (tiered subscription model), The

As more practices start to use imaging scans for diagnosing Alzheimer's disease, experts worry that the availability of the scans is getting ahead of availability of treatments for those who test positive. Treatment options are limited or not available for some forms of dementia. In one case, the family of an Arizona woman diagnosed with Alzheimer's through a scan refused to enroll her in an experimental study for fear of potential adverse side effects and instead turned to the Internet for treatments.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN